| pubmed-article:20016227 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20016227 | lifeskim:mentions | umls-concept:C0235032 | lld:lifeskim |
| pubmed-article:20016227 | lifeskim:mentions | umls-concept:C0576702 | lld:lifeskim |
| pubmed-article:20016227 | lifeskim:mentions | umls-concept:C0576704 | lld:lifeskim |
| pubmed-article:20016227 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:20016227 | lifeskim:mentions | umls-concept:C0205246 | lld:lifeskim |
| pubmed-article:20016227 | lifeskim:mentions | umls-concept:C1280464 | lld:lifeskim |
| pubmed-article:20016227 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:20016227 | pubmed:dateCreated | 2010-2-17 | lld:pubmed |
| pubmed-article:20016227 | pubmed:abstractText | Lhermitte's phenomenon, characterized by 'electric-shock' sensations precipitated by neck flexion, may develop during oxaliplatin treatment. Limited cases have been described previously and the pathophysiology underlying Lhermitte's phenomenon in oxaliplatin-treated patients has not been established. | lld:pubmed |
| pubmed-article:20016227 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20016227 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20016227 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20016227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20016227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20016227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20016227 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20016227 | pubmed:issn | 1423-0232 | lld:pubmed |
| pubmed-article:20016227 | pubmed:author | pubmed-author:LinCindy... | lld:pubmed |
| pubmed-article:20016227 | pubmed:author | pubmed-author:KiernanMatthe... | lld:pubmed |
| pubmed-article:20016227 | pubmed:author | pubmed-author:GoldsteinDavi... | lld:pubmed |
| pubmed-article:20016227 | pubmed:author | pubmed-author:FriedlanderMi... | lld:pubmed |
| pubmed-article:20016227 | pubmed:author | pubmed-author:KrishnanArun... | lld:pubmed |
| pubmed-article:20016227 | pubmed:author | pubmed-author:ParkSusanna... | lld:pubmed |
| pubmed-article:20016227 | pubmed:copyrightInfo | Copyright (c) 2009 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:20016227 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20016227 | pubmed:volume | 77 | lld:pubmed |
| pubmed-article:20016227 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20016227 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20016227 | pubmed:pagination | 342-8 | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:meshHeading | pubmed-meshheading:20016227... | lld:pubmed |
| pubmed-article:20016227 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20016227 | pubmed:articleTitle | Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity. | lld:pubmed |
| pubmed-article:20016227 | pubmed:affiliation | Prince of Wales Medical Research Institute and Prince of Wales Clinical School, Sydney, NSW, Australia. | lld:pubmed |
| pubmed-article:20016227 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20016227 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
